IRIS
RADAELLI, MARTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.823
NA - Nord America 1.198
EU - Europa 1.060
SA - Sud America 499
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.616
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.139
SG - Singapore 819
CN - Cina 497
BR - Brasile 436
SE - Svezia 308
RO - Romania 264
HK - Hong Kong 216
VN - Vietnam 136
IT - Italia 106
DE - Germania 100
RU - Federazione Russa 73
GB - Regno Unito 56
FI - Finlandia 34
IN - India 31
CA - Canada 27
NL - Olanda 26
AR - Argentina 24
JP - Giappone 23
MX - Messico 23
ZA - Sudafrica 21
PL - Polonia 18
TR - Turchia 18
BD - Bangladesh 17
IR - Iran 17
EC - Ecuador 16
IE - Irlanda 15
FR - Francia 14
ID - Indonesia 14
ES - Italia 10
AT - Austria 9
CO - Colombia 7
IQ - Iraq 7
UZ - Uzbekistan 6
CH - Svizzera 5
CL - Cile 5
PY - Paraguay 5
SA - Arabia Saudita 5
UA - Ucraina 5
JO - Giordania 4
AE - Emirati Arabi Uniti 3
CZ - Repubblica Ceca 3
EG - Egitto 3
LT - Lituania 3
PE - Perù 3
PK - Pakistan 3
TN - Tunisia 3
AL - Albania 2
DO - Repubblica Dominicana 2
EU - Europa 2
HU - Ungheria 2
MA - Marocco 2
NP - Nepal 2
PA - Panama 2
PT - Portogallo 2
UY - Uruguay 2
AZ - Azerbaigian 1
BB - Barbados 1
BE - Belgio 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GR - Grecia 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PH - Filippine 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 4.616
Salva come PNG Salva come JPEG
Città #
Singapore 339
Dallas 291
Hong Kong 214
Ashburn 127
Hefei 103
Shanghai 102
Beijing 79
Lawrence 72
Princeton 72
Munich 64
Ho Chi Minh City 58
Los Angeles 48
New York 48
São Paulo 42
Milan 38
Boardman 34
Moscow 30
Hanoi 26
Orem 21
Denver 16
Helsinki 16
Tokyo 16
Dublin 15
Montreal 15
Warsaw 15
Johannesburg 14
Rio de Janeiro 14
Turku 14
Manchester 13
Ankara 12
Rome 12
Chennai 11
Mexico City 11
Poplar 11
Amsterdam 10
Brooklyn 10
Chicago 10
London 10
Nuremberg 10
Phoenix 10
Stockholm 10
The Dalles 10
Brasília 9
Guangzhou 9
Mumbai 9
Da Nang 8
Dronten 8
Houston 8
Seattle 8
Tehran 8
Tianjin 8
Vienna 8
Haiphong 7
Pune 6
Ribeirão Preto 6
Tashkent 6
Washington 6
Bergamo 5
Campinas 5
Duque de Caxias 5
Osasco 5
Querétaro 5
Quito 5
Zurich 5
Amman 4
Aracaju 4
Atlanta 4
Belo Horizonte 4
Cesano Boscone 4
Changsha 4
City of London 4
Cotia 4
Curitiba 4
Frankfurt am Main 4
Goiânia 4
Guarulhos 4
Guayaquil 4
Hangzhou 4
Izmir 4
Lappeenranta 4
Medellín 4
Porto Alegre 4
Salvador 4
San Francisco 4
Santa Fe 4
Secaucus 4
Toronto 4
Araçatuba 3
Baghdad 3
Belford Roxo 3
Campina Grande 3
Campo Grande 3
Cerquilho 3
Charlotte 3
Dhaka 3
Feira de Santana 3
Fortaleza 3
Gronau 3
Guarapuava 3
Ikejiri 3
Totale 2.373
Salva come PNG Salva come JPEG
Nome #
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study 316
Application of Deep-Learning to NMOSD and Seronegative Patients with Limited NMOSD Manifestations 140
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study 103
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 80
Subclinical neurodegeneration in multiple sclerosis and neuromyelitis optica spectrum disorder revealed by optical coherence tomography 75
Autologous haematopoietic stem cell transplantation with thiotepa-cyclophosphamide conditioning in aggressive multiple sclerosis: clinical experience in eight patients 71
the multiple sclerosis knowledge Questionnaire: a self administered instrument of recently diagnosed patients 69
Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders 67
U-Fiber Leukoencephalopathy Due to a Novel Mutation in the TACO1 Gene 67
Magnetic Resonance Imaging Evaluation of Perivascular Space Abnormalities in Neuromyelitis Optica 66
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 66
Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimod 66
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response 65
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy 61
Caesarean section and infant formula feeding are associated with an earlier age of onset of multiple sclerosis 61
Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients 58
Cross-modal plasticity among sensory networks in neuromyelitis optica spectrum disorders 58
Dysregulation of MS risk genes and pathways at distinct stages of disease 57
In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis 57
Cohort profile: a collaborative multicentre study of retinal optical coherence tomography in 539 patients with neuromyelitis optica spectrum disorders (CROCTINO) 57
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis 56
A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis 54
Autologous haematopoietic stem cell transplantation in aggressive forms of neuromyelitis optica (NMO) and NMO spectrum disorders 53
Critical role for prokineticin 2 in CNS autoimmunity 51
Forceps minor damage and co-occurence of depression and fatigue in multiple sclerosis 50
Brain and cord imaging features in neuromyelitis optica spectrum disorders 50
Concurrence of NMOSD and ALS in a patient with hexanucleotide repeat expansions of C9orf72 50
Breastfeeding is not related to postpartum relapses in multiple sclerosis 49
Mapping white matter damage distribution in neuromyelitis optica spectrum disorders with a multimodal MRI approach 49
Clinical and MRI predictors of response to interferon‐beta and glatiramer acetate in relapsing–remitting multiple sclerosis patients 48
Smart watch, smarter EDSS: Improving disability assessment in multiple sclerosis clinical practice 48
Autologous Bone Marrow Transplantation for the Treatment of Multiple Sclerosis 47
Thiotepa-cyclophosphamide high-dose immunosuppressive therapy with autologous haematopoietic stem cell transplantation in aggressive forms of multiple sclerosis: results in 9 patients 47
Experience of an information aid for newly diagnosed multiple sclerosis patients: A qualitative study on the SIMS-Trial 46
THIOTEPA-CYCLOPHOSPHAMIDE HIGH-DOSE IMMUNOSUPPRESSIVE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN AGGRESSIVE FORMS OF MULTIPLE SCLEROSIS: RESULTS IN 9 PATIENTS 45
Evolving concepts in the treatment of relapsing multiple sclerosis 44
Natalizumab treatment after autologous haematopoietic stem cell transplantation in patients with aggressive multiple sclerosis 43
Depressive symptoms correlate with disability and disease course in multiple sclerosis patients: An Italian multi-center study using the Beck Depression Inventory 43
Functional brain connectivity abnormalities and cognitive deficits in neuromyelitis optica spectrum disorder 43
Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis 43
Application of deep-learning to NMOSD and unclassified seronegative patients 42
Comparative study of mitoxantrone efficacy profile in patients with relapsing-remitting and secondary progressive multiple sclerosis. 42
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs. 42
Are Recurrent Myelitis a Prodromic Phase of Inflammatory Diseases or a Distinct Inflammatory Condition? 41
Optical coherence tomography and visual-evoked potentials: which is more sensitive in multiple sclerosis? 41
Mapping regional grey and white matter atrophy in relapsing-remitting multiple sclerosis. 41
Efficacy and tolerability of natalizumab in relapsing-remitting multiple sclerosis patients: A post-marketing observational study 41
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis 41
Efficacy and safety of nabiximols (Sativex (R)) on multiple sclerosis spasticity in a real-life Italian monocentric study 40
Evoked Potential Abnormalities Predict Disability Progression at 5 Years in Patients with CIS 40
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks. 40
Use of brain MRI and gene expression atlases to reconstruct the pathophysiology of autoimmune neurological disorders: The proof-of-concept of NMOSD 39
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 39
Neuromyelitis optica spectrum disorders: Long-term safety and efficacy of rituximab in Caucasian patients 39
Functional network connectivity abnormalities in multiple sclerosis: Correlations with disability and cognitive impairment 38
Comparative effectiveness of dimethylfumarate and fingolimod in an Italian monocentric cohort of relapsing remitting multiple sclerosis patients 37
Evoked potentials scores: a useful tool in monitoring and predicting the course of multiple sclerosis? 37
Necrotic-hemorrhagic myelitis: A rare malignant variant of parainfectious acute disseminated encephalomyelitis in childhood 37
Prognostic value of serum neurofilaments in patients with clinically isolated syndromes 37
Disclosing the diagnosis of multiple sclerosis: The Profile Project 37
Oral fingolimod (FTY720) in multiple sclerosis: Two-year results of a phase II extension study 37
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks. 37
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results 37
Signs and symptoms of COVID-19 in patients with multiple sclerosis 36
Evoked potential abnormalities predict disability progression at 5 years in patients with CIS 36
Identifying neuropathic pain in patients with multiple sclerosis: a cross-sectional multicenter study using highly specific criteria. 36
Mitoxantrone: benefits and risks in multiple sclerosis patients 35
Sars-CoV2 infection in pregnant women with multiple sclerosis 34
White Matter Myelin Alterations are Diffuse in Neuromyelitis Optica Spectrum Disorders and Prevail on Axonal Damage 34
Dynamic pattern of clinical and MRI findings in a tumefactive demyelinating lesion: a case report 34
Long-term management of natalizumab discontinuation in a large monocentric cohort of multiple sclerosis patients. 34
MGAT5 and disease severity in progressive multiple sclerosis 34
Neuromyelitis optica: Concepts in evolution 34
Artificial Intelligence on Conventional Magnetic Resonance Images for the Diagnosis of Neuromyelitis Optica Spectrum Disorders 34
Regional gray matter atrophy is largely unrelated to white matter tissue loss in relapsing remitting multiple sclerosis. 33
Neuromyelitis optica remission after allo-SCT: results in 2 patients and correlation with T- and B-cell biomarkers of tolerance 33
Oral corticosteroids for multiple sclerosis relapse 33
Brain and Spinal Cord Imaging Features in Neuromyelitis Optica Spectrum Disorders 33
NMO spectrum disorder and optic neuritis: are VEPs useful? 32
Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease prediction. 32
Hippocampal-DMN disconnectivity in MS is related to WM lesions and depression 32
Recurrence of disease activity after repeated Natalizumab withdrawals. 31
Multiple sclerosis progression is not associated with birth timing in Italy 31
Differential diagnosis of optic neuritis in neuromyelites optica and multiple sclerosis: are VEPs useful? 31
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: An Italian multicenter study 31
White matter myelin alterations are diffuse in Neuromyelitis Optica spectrum disorders and prevail on axonal damage 31
Spinal cord atrophy in neuromyelitis optica is spatially associated to spinal cord lesions and clinical disability 30
Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial. 28
Practice of yoga may cause damage of bothsciaticnerves: a case report 28
Stem Cell-Based Therapies, Remyelination, and Repair Promotion in the Treatment of Multiple Sclerosis 27
Hippocampal Regional Vulnerability to Damage Differs Between MS and Neuromyelitis Optica 27
Revealing structural and clinical heterogeneity in the spectrum of neuromyelitis optica with unsupervised machine learning 26
Global and regional hippocampal volumes are preserved in neuromyelitis optica spectrum disorders and do not contribute to cognitive impairment 26
Hippocampal regional vulnerability to damage differs between MS and neuromyelitis optica 26
Global and regional hippocampal volumes are preserved in neuromyelitis optica spectrum disorders and do not seem to be related to cognitive impairment 24
Revealing structural and clinical heterogeneity in the spectrum of neuromyelitis optica with unsupervised machine learning 24
Golbal and Regional Hippocampal Volumes Are Preserved In Neuromyelitis Optica and Do not Seem to Be Related to Cognitive Impairment 23
White matter myelin alterations are diffuse in Neuromyelitis Optica Spectrum Disorders and prevail on axonal damage 23
Mr t2-relaxation time as an indirect measure of brain water accumulation in neuromyelitis optica spectrum disorders 22
Spinal cord atrophy in neuromyelitis optica spectrum disorders is associated to spinal cord lesions and clinical disability 22
Totale 4.641
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.504
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.504
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 2 2 0 3 0 1 0
2021/202244 0 0 0 30 1 2 1 3 2 3 0 2
2022/2023504 182 129 55 2 5 60 19 15 19 6 9 3
2023/2024229 7 26 22 26 27 42 4 20 0 7 10 38
2024/20251.593 130 14 20 59 69 85 434 102 262 131 121 166
2025/20262.288 339 376 378 679 350 166 0 0 0 0 0 0
Totale 4.712